Cargando…

Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release

OBJECTIVE: To assess the ability of medication-assisted weight loss to prevent diabetes as a function of the baseline weighted Cardiometabolic Disease Staging (CMDS) score. RESEARCH DESIGN AND METHODS: We pooled data from 3,040 overweight and obese participants in three randomized controlled trials—...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Fangjian, Garvey, W. Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481985/ https://www.ncbi.nlm.nih.gov/pubmed/28455281 http://dx.doi.org/10.2337/dc17-0088

Ejemplares similares

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management
por: Garvey, William Timothy
Publicado: (2013)

Changes in Gut Microbiota–Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial
por: Heianza, Yoriko, et al.
Publicado: (2018)

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

Weight-Loss Practices and Weight-Related Issues Among Youth With Type 1 or Type 2 Diabetes
por: Lawrence, Jean M., et al.
Publicado: (2008)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

Weight Loss, Glycemic Control, and Cardiovascular Disease Risk Factors in Response to Differential Diet Composition in a Weight Loss Program in Type 2 Diabetes: A Randomized Controlled Trial
por: Rock, Cheryl L., et al.
Publicado: (2014)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

An Automated Internet Behavioral Weight-Loss Program by Physician Referral: A Randomized Controlled Trial
por: Thomas, J. Graham, et al.
Publicado: (2015)

Weight loss efficacy of a novel mobile Diabetes Prevention Program delivery platform with human coaching
por: Michaelides, Andreas, et al.
Publicado: (2016)

Calorie Restriction and Matched Weight Loss From Exercise: Independent and Additive Effects on Glucoregulation and the Incretin System in Overweight Women and Men
por: Weiss, Edward P., et al.
Publicado: (2015)

Weight Loss Strategies Associated With BMI in Overweight Adults With Type 2 Diabetes at Entry Into the Look AHEAD (Action for Health in Diabetes) Trial
por: Raynor, Hollie A., et al.
Publicado: (2008)

PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial
por: Huang, Tao, et al.
Publicado: (2015)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

Successful long-term weight loss among participants with diabetes receiving an intervention promoting an adapted Mediterranean-style dietary pattern: the Heart Healthy Lenoir Project
por: Embree, Genevieve G R, et al.
Publicado: (2017)

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report
por: Homola, Jaclyn, et al.
Publicado: (2018)

Weight Change in Diabetes and Glycemic and Blood Pressure Control
por: Feldstein, Adrianne C., et al.
Publicado: (2008)

Association Between Inpatient Sleep Loss and Hyperglycemia of Hospitalization
por: DePietro, Regina H., et al.
Publicado: (2017)

Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy
por: Lopez, Prudence, et al.
Publicado: (2014)

Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry
por: Bramlage, Peter, et al.
Publicado: (2017)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study(1)(2)(3)
por: Garvey, W Timothy, et al.
Publicado: (2012)

Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?
por: Paszkowiak, Maria, et al.
Publicado: (2023)

Neonatal Diabetes With End-Stage Nephropathy: Pancreas transplantation decision
por: Esmatjes, Enric, et al.
Publicado: (2008)

Drivers of weight loss in a CDC-recognized digital diabetes prevention program
por: Painter, Stefanie L, et al.
Publicado: (2020)

Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey
por: Otani, Toshika, et al.
Publicado: (2016)

Stages of change for physical activity and dietary habits in persons with type 2 diabetes included in a mobile health intervention: the Norwegian study in RENEWING HEALTH
por: Holmen, Heidi, et al.
Publicado: (2016)

Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity
por: Tomah, Shaheen, et al.
Publicado: (2019)

Association of a lifestyle score with cardiometabolic markers among individuals with diabetes: a cross-sectional study
por: Baechle, Christina, et al.
Publicado: (2023)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy
por: Chen, Harn-Shen, et al.
Publicado: (2008)

Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial
por: Musen, Gail, et al.
Publicado: (2008)

Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
por: Feng, Yan, et al.
Publicado: (2008)

A1C but Not Serum Glycated Albumin Is Elevated in Late Pregnancy Owing to Iron Deficiency
por: Hashimoto, Kunihiko, et al.
Publicado: (2008)

Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2-Day In-Hospital Diabetes Educational Program: The Joetsu Diabetes Prevention Trial
por: Kawahara, Tetsuya, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gj71dosqh3kdfpe5b6o04kie42